HD Visual Learning
2D Animations
Case Study
Patient Avatar
VR Room Experience
2D Animations
ICIs: Mechanistic Effects, Synergy and AE Management
Chemo ICI: Rationale for combined use of anti-PD(L)1 therapy and chemotherapy as a first-line treatment strategy in advanced NSCLC without targetable mutations
MOA: Evaluating the mechanisms of checkpoint inhibition in NSCLC and relevant adverse events
Applying Multidisciplinary Guidelines
for Management of Potential Adverse Events with Checkpoint Inhibition
Evaluating the Mechanisms of Checkpoint Inhibition in NSCLC
and the Complementary Effects of Checkpoint Inhibitors and Chemotherapy
Case Study
NSCLC – Shared Decision Making Case Study
Patient Avatar
The ENCOMPASS Experience:
Rapidly Evolving Evidence Drives Change in Clinical Practice for Patients with Non-small Cell Lung Cancer
VR Room Experience
Personalized Medicine for Metastatic Non-Small Cell Lung Cancer: Leveraging Immune Competence with Dr. Heather Wakelee.
HD Animation Viewing
Interactive Learning Tools
HD Animation Viewing
ICIs: Mechanistic Effects, Synergy and AE Management
Chemo ICI: Rationale for combined use of anti-PD(L)1 therapy and chemotherapy as a first-line treatment strategy in advanced NSCLC without targetable mutations
MOA: Evaluating the mechanisms of checkpoint inhibition in NSCLC and relevant adverse events
Applying Multidisciplinary Guidelines
for Management of Potential Adverse Events with Checkpoint Inhibition
Evaluating the Mechanisms of Checkpoint Inhibition in NSCLC
and the Complementary Effects of Checkpoint Inhibitors and Chemotherapy
Interactive Learning Tools
